Search

Your search keyword '"Creisson, A"' showing total 142 results

Search Constraints

Start Over You searched for: Author "Creisson, A" Remove constraint Author: "Creisson, A"
142 results on '"Creisson, A"'

Search Results

1. Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

2. Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

3. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

7. Éducation thérapeutique du patient, concepts et mise en œuvre

8. Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline

9. Abstract P4-01-04: Phase IV multicenter study evaluating RWE and the safety of talazoparib in patients with locally advanced or metastatic negative HER2 breast cancer and a BRCA1/2 mutation (ViTAL) - Cohort 2: patients treated according to the EMA

10. Abstract P4-01-20: Phase IV study evaluating talazoparib in patients with locally advanced or metastatic negative HER2 breast cancer and a somatic or germline BRCA1/2 mutation (ViTAL) – Analysis of cohort 1 according to hormonal receptor status

11. Abstract P1-18-28: Phase IV study evaluating effectiveness and safety of talazoparib in patients with locally advanced or metastatic HER2 negative breast cancer and a BRCA1 or BRCA2 mutation (ViTAL)

12. Abstract P4-01-04: Phase IV multicenter study evaluating RWE and the safety of talazoparib in patients with locally advanced or metastatic negative HER2 breast cancer and a BRCA1/2 mutation (ViTAL) - Cohort 2: patients treated according to the EMA

13. Abstract P4-01-20: Phase IV study evaluating talazoparib in patients with locally advanced or metastatic negative HER2 breast cancer and a somatic or germline BRCA1/2 mutation (ViTAL) – Analysis of cohort 1 according to hormonal receptor status

14. Abstract P1-18-28: Phase IV study evaluating effectiveness and safety of talazoparib in patients with locally advanced or metastatic HER2 negative breast cancer and a BRCA1 or BRCA2 mutation (ViTAL)

15. Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA

18. Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

20. Orthostatic mesodiencephalic dysfunction after decompressive craniectomy

22. Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA.

23. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

24. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

27. Éducation thérapeutique du patient, concepts et mise en œuvre

28. Radiothérapie des cancers du sein inflammatoires

29. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

31. [Radiation therapy in inflammatory breast cancer]

32. [Radiation-induced bronchiolitis obliterans with organizing pneumonia]

33. Complications pulmonaires de la radiothérapie après cancer du sein : penser à la BOOP

34. Aberrométrie et sensibilité aux contrastes chez le patient pseudophaque. Évaluation d’un implant asphérique : étude comparative

36. Haematological Evaluation of Weekly Therapy with Topotecan for the Treatment of Recurrent Ovarian Cancer Resistant to Platinum-Based Therapy

37. [Integrating patient education in your oncology practice]

38. Orthostatic mesodiencephalic dysfunction after decompressive craniectomy

39. Adrénoleucodystrophie liée à l'X chez une proposante symptomatique : présentation clinique, diagnostic biologique et conséquences familiales

41. Profil médical des enfants orientés par la Commission Départementale de l'Éducation Spéciale du Var vers des structures médico-sociales

42. Influence of the comprehensive geriatric assessment (CGA) in elderly metastatic cancer patients. Analysis from a prospective cohort of 1048 patients.

43. Macroprolactinémie, une variété d'hyperprolactinémie. À propos de cinq observation

44. Annual Meeting of the World Federation of Neurology-Research Group on Neuroepidemiology (Part 2 of 2)

45. Annual Meeting of the World Federation of Neurology-Research Group on Neuroepidemiology (Part 1 of 2)

46. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain

47. [Aberrometry and contrast sensitivity after cataract surgery: aspherical IOL evaluation]

48. [Study of pupillary motility after implantation of an iris claw lens (Artisan) in a phakic population with severe myopia]

49. [X-linked adrenoleukodystrophy in a female proband: clinical presentation, biological diagnosis and family consequences]

50. [The medical profile of children for whom a medico-social institution is recommended by the Departmental Commission of Special Education in Var]

Catalog

Books, media, physical & digital resources